Articles On Genetic Technologies (ASX:GTG)

Highlights Imugene has advanced its ongoing Phase 1 MAST study with the first patients receiving dosing in the intratumoral (IT) and intravenous (IV) cohorts of CF33-hNIS in combination with Pembrolizumab. The study is focused on measu...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX got an Data Nerd Bailout when the ABS dropped happy-ish CPI data The benchmark recovers from early flesh wounds to end the day flat Ordinary Aussies ‘outraged’ over changes to super that will never, ever affect them The market has...

The ASX climbed 0.4% today after investors threatened it with a stick Mt Monger (ASX:MTM) wins the day by securing funding for it’s Canadian REE play New consumer survey suggests 42% of shoppers might be dumber than previously feared   Au...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX fell today because US data gave Wall Street the willies on Friday A month’s worth of shipping data shows coal shipments to China are on the rise Qantas celebrates last week’s $1bn profit by slashing regional services. Again   Toda...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX recovered from an early stumble to finish the day up-ish Meta wants you to pay $12 a month for the privilege of being a captive audience Some Big Names have had shockers as earnings relentlessly keep rolling in   The benchmark has...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX 200 climbs about 0.8% on a happier day than yesterday Unemployment jump to 3.7% in January eases concern over future rate rise severity NSW Government’s coal policy kicks miners square in the cokers   Good afternoon, and welcome to th...

Genetic Technologies (ASX:GTG) has announced the publication of a new research paper in the peer-reviewed journal Breast Cancer Research and Treatment.

ASX health stocks fall 1.75% for the past five days Several companies announce successful capital raises Healius drops 15% in the past five days as H1 FY23 results disappoint Healthcare and life sciences expert Scott Power, who has been a...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX slumps even lower after lunch to end the day down around 0.5% China’s demands for the return of “weather balloon” debris met with hearty Pentagon chuckles Terramin’s bid to reopen a sub-winery mine shut down by the SA government   It’...

Genetic Technologies (ASX:GTG) has announced that it has entered into definitive agreements with several institutional investors for the purchase and sale of American Depositary Shares to raise approximately US$5 million.

Psychedelic drugs remain the talk of an otherwise depressed market today Newmont bid for Newcrest helps drive Materials sector higher ASX benchmark limps home to be down 0.25% at the end of a gloomy Monday   It’s not exactly been a stella...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Qantas boss Alan Joyce says “sorry we suck” to an angry Australia Mortgage holders are bricking it as fixed interest rate periods end Spacetalk backs up yesterday’s gains with another massive day at the market. It’s the end of the day at...

Genetic Technologies (GTG) launches a new cancer risk assessment test designed to evaluate a woman’s risk of developing breast or ovarian cancer The “world-first” test combines GTG’s GeneType platform with other clinical risk factors to...

03 Feb 2023 - A snapshot of the stocks on the move featuring Liontown Resources (ASX:LTR), Genetic Technologies (ASX: GTG) and Southern Hemisphere Mining (ASX:SUH).

This content is created by Smallcaps Authors. [Author : Filip Karinja] A ground-breaking comprehensive risk assessment test is set to be introduced by Genetic Technologies (ASX: GTG) to assesses the likelihood that a woman will develop br...

ShareCafeASX 0.37% higher at noon after S&P 500 hits highest level in 5 months by Peter Milios   At noon, the S&P/ASX 200 is 0.37 per cent higher at 7,539.60. Coal miners are facing pressure as coal prices decrease, with Whitehaven...

ShareCafeStocks of the Hour: LTR, GTG, SUH                    Liontown Resources (ASX:LTR) announced that their Open pit mining operations have commenced at their Kathleen Valley lithium project in WA. In response, Liontown’s Managing...

Genetic Technologies (ASX:GTG) rose over 30% this morning after announcing an imminent launch of the world’s first comprehensive risk test for breast and ovarian cancer. The Risk Assessment Test will be able to evaluate a woman’s risk of de...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Genetic Technologies (ASX:GTG) has announced that it will form a strategic alliance with QIAGEN, a global leader in molecular testing with operations in 35 countries.

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

Genetic Technologies (GTG) to form a strategic alliance with global leader in molecular testing, QIAGEN The alliance will enable the establishment and development of a ‘Centre of Excellence’ facility in Australia The relationship will...

Aussies warned of impending critical chicken meat shortage Data shows food prices rose a staggering 9.4% in Q4 CY2022 Lode Resources laughs all the way to the bank on the back of a 191.67% rise today   I don’t want to alarm anyone unduly,...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

IMF says Everything’s War on Everything is great, except for the bad bits Short-sighted mortgage takers are bricking it over projected 4.1% interest rates in ‘23 Strong quarterlies have driven huge gains among well-placed small caps today...

ASX 200 holds steady around +0.8% since lunch Australian Pacific Coal CEO David Conry has left the company. Abruptly. Bain Capital making all the right noises about bringing Virgin back to the bourse   All up, it’s been a pretty tidy old...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX 200 rose a tidy 1.29% today with all sectors in the green ABS releases Aussie migrant data employment outcomes for the first time  ACCC gives the thumbs down to Telstra and TPG’s merger plans   The ASX 200 gained 1.29% today and...

ASX takes a pre-Christmas bath, dragged down by InfoTech and Discretionary Asian markets fall lower today as Japan widens yield target range PolarX is still ruling the playground after one of the big kids said it was cool With apologies t...

The ASX 200 was in the red again, down 0.21% today 9 out 11 sectors finished lower led by Real Estate, with Energy and Materials gaining Stockmarkets head into the festive period in a downbeat mood, Oanda says   The ASX 200 was down 0.21%...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX 200 down 0.75%, dropping for the third straight day Small cap index falls 0.0.56% and 7 out 11 sectors finish lower China could reopen next year with ‘seismic’ implications for the rest of the world   The local bourse has dropped for...

Genetic Technologies (ASX:GTG) has announced the publication of a peer-reviewed paper describing the development and validation of the polygenic risk scores that underlie the risk predictions for cardiovascular diseases and type 2 d...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX 200 down 0.55% on lower than normal volume  Small cap index falls 0.96% and 10 out 11 sectors finish lower Economy grows for the fourth consecutive quarter, up 0.6%    The ASX200 was down 0.55% today, and the ASX Emerging Companies...

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

ASX200 weakens in arvo trade ASX small caps index sheds 0.3% Victory Goldfields is really, really winning REE   Just ahead of the close on Thursday, the S&P/ASX 200 was doing its best to shake off a decent session, despite most sector...

ASX200 and small caps end about 0.4% down BNPLs come out of hibernation WA1 is finding even more niobium   Local markets failed to launch on Wednesday, unlike the missile strikes early this morning AEDT, which reportedly crossed the borde...

Hump Day! Who doesn’t love a crazy old Hump Day? Because this one seems to have been a bit manic for a number of people – which means that there’s likely to have been a few tidbits and stories that you missed. So, pull up a milk crate in th...

ASX 200 hits 4-day peak. Applause! The little market rises about 0.2% higher The skies the limit for Macca’s bound Skyfii   The S&P/ASX 200 is ahead by about 0.35% at the close of trade in Sydney on Tuesday after hitting a four-day hi...

ASX 200 bounces back to grind out a 0.47% win for the day HitIQ’s new deals look set to cement its place in professional sports Star gets some heartburn-inducing mail from regulators in Queensland If you’re like me and can’t read the word...

The ASX 200 falls flat  Small caps drop -0.1% Inflation inflates We’ll get to this in a moment. Via Google FinanceJosh, Reuben, Gregor and other bloodhounds have further details, as well.   In the meantime… Yikes. Annual inflation in the...